Medtronic Announces Closing of Public Offering of Euro6.25 Billion of Senior Notes and Redemption of Outstanding Senior Notes Medical Device Investing
Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using DehydraTECH Technology in Delivering Antiviral Drugs Biotech Investing
Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using its DehydraTECH technology in Delivering Antiviral Drugs Biotech Investing
Better Plant Sciences Subsidiary NeonMind Signs Psilocybin Supply Agreement for Clinical Trials Cannabis Investing News
U.S. FDA Approves Pfizer's XELJANZ® for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis Pharmaceutical Investing
Abbott's FreeStyle® Libre 3 System Receives CE Mark - Features World's Smallest, Thinnest Sensor with Best-in-Class Performance at the Same Low Cost for People with Diabetes Medical Device Investing
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury Biotech Investing
Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome Biotech Investing
